The Molecular Adsorbent Recirculating System (MARS®) in the intensive care unit: a rescue therapy for patients with hepatic failure
Author:
Open Access
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 10 (1) , 118
Abstract
Treatment in the intensive care unit of patients with end-stage liver disease has been limited. Liver transplantation has been a major improvement in this and has become standard in the management of these patients. However, many patients die awaiting liver transplantation, mainly due to the scarcity of organ donors. Conventional hemodialysis techniques have little or no effect on liver detoxification and do not improve the prognosis of these patients. In patients with acute hepatic failure, the majority of endogenous toxins leading to organ failure and accumulating in the blood are bound to albumin; therefore, the concept of albumin dialysis is of major interest. To date, the most widely developed system has been the Molecular Adsorbent Recirculating System (MARS®), which is based on the selective removal of albumin-bound toxins from the blood. MARS® enables simultaneous liver and kidney detoxification, improving the patient's clinical condition. It is a major improvement in the management of patients with hepatic failure that could permit, when appropriately indicated, recovery from an acute episode and enhance the chances of survival while waiting for an available organ donor.Keywords
This publication has 17 references indexed in Scilit:
- In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD)Hepatology, 2004
- Assessment of resin perfusion in hepatic failurein vitroandin vivoWorld Journal of Gastroenterology, 2004
- Prometheus® – a new extracorporeal system for the treatment of liver failure☆Journal of Hepatology, 2003
- Successful MARS Treatment in Severe Cholestatic Patients with Acute on Chronic Liver FailureArtificial Organs, 2003
- Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: A prospective controlled trialLiver Transplantation, 2003
- Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitisJournal of Hepatology, 2003
- Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled studyHepatology, 2002
- Application of Molecular Adsorbent Recirculating System® in patients with severe liver failure after hepatic resection or transplantation: initial single‐centre experiencesLiver International, 2002
- Extracorporeal Detoxification Using the Molecular Adsorbent Recirculating System for Critically Ill Patients with Liver FailureJournal of the American Society of Nephrology, 2001
- Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trialLiver Transplantation, 2000